100 related articles for article (PubMed ID: 7520872)
1. Identification of imidazole as L-arginine-competitive inhibitor of porcine brain nitric oxide synthase.
Mayer B; Klatt P; Werner ER; Schmidt K
FEBS Lett; 1994 Aug; 350(2-3):199-202. PubMed ID: 7520872
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole.
Mayer B; Klatt P; Werner ER; Schmidt K
Neuropharmacology; 1994 Nov; 33(11):1253-9. PubMed ID: 7532811
[TBL] [Abstract][Full Text] [Related]
3. The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain.
Klatt P; Schmid M; Leopold E; Schmidt K; Werner ER; Mayer B
J Biol Chem; 1994 May; 269(19):13861-6. PubMed ID: 7514595
[TBL] [Abstract][Full Text] [Related]
4. Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay.
Alderton WK; Boyhan A; Lowe PN
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):195-201. PubMed ID: 9576868
[TBL] [Abstract][Full Text] [Related]
5. Binding of L-arginine and imidazole suggests heterogeneity of rat brain neuronal nitric oxide synthase.
Gorren AC; Schmidt K; Mayer B
Biochemistry; 2002 Jun; 41(24):7819-29. PubMed ID: 12056914
[TBL] [Abstract][Full Text] [Related]
6. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
[TBL] [Abstract][Full Text] [Related]
7. Characterization of interactions among the heme center, tetrahydrobiopterin, and L-arginine binding sites of ferric eNOS using imidazole, cyanide, and nitric oxide as probes.
Berka V; Tsai AL
Biochemistry; 2000 Aug; 39(31):9373-83. PubMed ID: 10924132
[TBL] [Abstract][Full Text] [Related]
8. Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate.
Klatt P; Schmidt K; Uray G; Mayer B
J Biol Chem; 1993 Jul; 268(20):14781-7. PubMed ID: 7686905
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation.
Klatt P; Schmidt K; Brunner F; Mayer B
J Biol Chem; 1994 Jan; 269(3):1674-80. PubMed ID: 7507482
[TBL] [Abstract][Full Text] [Related]
10. The dual mode of inhibition of calmodulin-dependent nitric-oxide synthase by antifungal imidazole agents.
Wolff DJ; Datto GA; Samatovicz RA
J Biol Chem; 1993 May; 268(13):9430-6. PubMed ID: 7683652
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide.
Griscavage JM; Fukuto JM; Komori Y; Ignarro LJ
J Biol Chem; 1994 Aug; 269(34):21644-9. PubMed ID: 7520440
[TBL] [Abstract][Full Text] [Related]
12. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase.
Heinzel B; John M; Klatt P; Böhme E; Mayer B
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):627-30. PubMed ID: 1371384
[TBL] [Abstract][Full Text] [Related]
13. Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction.
McMillan K; Masters BS
Biochemistry; 1993 Sep; 32(38):9875-80. PubMed ID: 7691172
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding of [3H]-L-NG-nitro-arginine in rat brain.
Michel AD; Phul RK; Stewart TL; Humphrey PP
Br J Pharmacol; 1993 Jun; 109(2):287-8. PubMed ID: 7689392
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic distribution of [3H]L-NG-nitro-arginine binding in rat brain.
Kidd EJ; Michel AD; Humphrey PP
Neuropharmacology; 1995 Jan; 34(1):63-73. PubMed ID: 7542749
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles.
Wolff DJ; Datto GA; Samatovicz RA; Tempsick RA
J Biol Chem; 1993 May; 268(13):9425-9. PubMed ID: 7683651
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
18. Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide.
Kotsonis P; Fröhlich LG; Shutenko ZV; Horejsi R; Pfleiderer W; Schmidt HH
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):767-76. PubMed ID: 10698705
[TBL] [Abstract][Full Text] [Related]
19. NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.
Olken NM; Marletta MA
Biochemistry; 1993 Sep; 32(37):9677-85. PubMed ID: 7690590
[TBL] [Abstract][Full Text] [Related]
20. X-ray absorption spectroscopic analysis of the high-spin ferriheme site in substrate-bound neuronal nitric-oxide synthase.
Cosper NJ; Scott RA; Hori H; Nishino T; Iwasaki T
J Biochem; 2001 Aug; 130(2):191-8. PubMed ID: 11481035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]